Centene Corporation filed a current report on September 16, 2026, under Item 7.01 Regulation FD Disclosure, disclosing the company's participation in the Deutsche Bank 2026 Healthcare Summit and its reaffirmation of full year 2026 earnings guidance.

Key Highlights

  • Conference date: Centene participated in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026, at 9:00 a.m. EDT.
  • GAAP EPS guidance reaffirmed: Management reaffirmed full year 2026 GAAP diluted EPS guidance of greater than $3.11.
  • Adjusted EPS guidance reaffirmed: Full year 2026 adjusted diluted EPS guidance of greater than $4.80 was also reaffirmed.
  • Investor discussions: Management indicated it would continue discussions with investors through the week of September 21.
  • Non-GAAP reconciliation reference: The company directed readers to the press release filed as Exhibit 99.1 to the filing dated July 28, 2026, for a reconciliation of GAAP diluted EPS to adjusted diluted EPS.

Centene Discloses Guidance Reaffirmation at Deutsche Bank Summit

Centene Corporation (NYSE:CNC), a managed care company incorporated in Delaware and headquartered in St. Louis, Missouri, disclosed through its Regulation FD filing that members of management participated in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026. According to the filing, management discussed the company's business and financial results during the event and in subsequent investor conversations scheduled to continue through the week of September 21.

The filing states that management reaffirmed full year 2026 GAAP diluted earnings per share guidance of greater than $3.11 and full year adjusted diluted EPS guidance of greater than $4.80. The company noted that the 2026 full year guidance constitutes a forward-looking statement and is subject to risks and uncertainties described in the filing, including changes in government healthcare program funding, fluctuations in medical costs, competition, and regulatory developments affecting programs such as the Affordable Care Act.

Regarding its non-GAAP financial presentation, the company disclosed that adjusted diluted EPS excludes items such as amortization of acquired intangible assets and acquisition and divestiture related expenses. The company stated that it "strongly encourages investors to review its consolidated financial statements and publicly filed reports in their entirety" and cautioned that its non-GAAP measures "may differ from similar measures used by other companies, even when similar terms are used to identify such measures." The filing specifies that the Item 7.01 disclosure "shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934."

What Was Disclosed

Centene Corporation's September 16, 2026 current report disclosed the company's participation in the Deutsche Bank 2026 Healthcare Summit and reaffirmed its full year 2026 GAAP diluted EPS guidance of greater than $3.11 and adjusted diluted EPS guidance of greater than $4.80.